Literature DB >> 6401581

Cancer statistics, 1983.

E Silverberg.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6401581

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  9 in total

Review 1.  Prevention and the elderly: risk factors.

Authors:  R L Kane; R A Kane; S B Arnold
Journal:  Health Serv Res       Date:  1985-02       Impact factor: 3.402

2.  Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. A Southwest Oncology Group Report.

Authors:  H J Eyre; J M Quagliana; J R Eltringham; J Frank; R M O'Bryan; B McDonald; S E Rivkin
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

3.  Clinical trials in colorectal cancer: experience of the Gastrointestinal Tumor Study Group and the Southwest Oncology Group.

Authors:  R M Bukowski
Journal:  Int J Colorectal Dis       Date:  1987-06       Impact factor: 2.571

4.  5-fluorouracil, adriamycin, and BCNU (FAB) combination chemotherapy for advanced gastric cancer.

Authors:  M Lopez; C F Perno; L Di Lauro; P Papaldo
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Active specific immunotherapy of Dukes B2 and C colorectal carcinoma: comparison of two doses of the vaccine.

Authors:  J M Jessup; C M McBride; F C Ames; L Guarda; D M Ota; M M Romsdahl; R G Martin
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Risk of stomach cancer after gastric surgery for benign conditions. A case-control study.

Authors:  R S Sandler; M D Johnson; K L Holland
Journal:  Dig Dis Sci       Date:  1984-08       Impact factor: 3.199

Review 7.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

8.  Antigenicity of newly established colorectal carcinoma cell lines.

Authors:  L G Durrant; R A Robins; M V Pimm; A C Perkins; N C Armitage; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

9.  Plasmodium yoelii infection inhibits murine leukaemia WEHI-3 cell proliferation in vivo by promoting immune responses.

Authors:  Zhen-Zhen Tong; Zheng-Ming Fang; Qi Zhang; Yun Zhan; Yue Zhang; Wan-Fang Jiang; Xiao Hou; Yong-Long Li; Ting Wang
Journal:  Infect Dis Poverty       Date:  2018-05-16       Impact factor: 4.520
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.